Table 3.
CHD risk and stroke risk in subjects depending on the number of MS components.
| Men | Women | |||||
|---|---|---|---|---|---|---|
| n | CHD risk (%) | Stroke risk (%) | n | CHD risk (%) | Stroke risk (%) | |
| 1 | 62 | 17.5 ± 11.4 | 5.0 ± 5.55 | 23 | 6.3 ± 5.0 | 3.1 ± 5.1 |
| 2 | 231 | 24.0 ± 14.9 | 11.1 ± 13.0 | 102 | 12.1 ± 8.6 | 6.4 ± 6.3 |
| 3 | 235 | 26.6 ± 17.0 | 10.6 ± 12.0 | 191 | 13.6 ± 9.2 | 8.5 ± 12.5 |
| 4 | 182 | 29.8 ± 18.6 | 11.5 ± 13.1 | 236 | 16.8 ± 11.5 | 9.5 ± 12.3 |
| 5 | 86 | 30.6 ± 20.7 | 8.7 ± 10.6 | 166 | 18.4 ± 11.3 | 8.6 ± 7.8 |
| F value | 8.65 | 4.14 | 13.3 | 3.0 | ||
| p | 0.000 | 0.003 | 0.000 | 0.017 |
Data are expressed as mean ± SD. CHD: coronary heart disease; MS: metabolic syndrome.